Search Results for: US Stem Cell

Yamanaka on making iPS cells from each patient: ‘in reality, we cannot do that’

/ / 1 Comment

One of the big issues related to using induced pluripotent stem (iPS) cells is cost. To make iPS cells from each patient for subsequent stem cell-based treatment would cost a fortune, by some estimates $200,000 or more per patient if done one-by-one. It could easily end up not being covered by insurances companies and Medicare, […]

Yamanaka on making iPS cells from each patient: ‘in reality, we cannot do that’ Read More »

Eight simple reasons not to get an unlicensed stem cell treatment: reason 1 is lost health insurance

/ / 12 Comments

Patients ask me all the time about stem cell treatments. Some are curious. Some have already had treatments. Others are very seriously considering a treatment, but haven’t done so yet. Some are open-minded. Some are not. Some are angry with me for my track record of criticizing for-profit, unlicensed clinics offering stem cell treatments. In

Eight simple reasons not to get an unlicensed stem cell treatment: reason 1 is lost health insurance Read More »

Money and stem cell ‘miracles’: Pluristem questioned on ethics

/ / 1 Comment

Pluristem Therapeutics Inc. is a publicly traded (NASDAQ) biotech Israeli company that is developing stem cell treatments based on the use of expanded placental stem cells called PLX cells. The Pluristem PLX drug is not approved for treating patients at this time in any country, however Pluristem has treated a handful of patients via something

Money and stem cell ‘miracles’: Pluristem questioned on ethics Read More »

Disease Focus Series

/ / 3 Comments

Cancer Stem Cells: a new target Disease Focus Series: Cancer Disease Focus Series: HIV/AIDS Disease Focus Series: Spinal Cord InjuryDisease Focus Series: Osteoarthritis research moving forward Disease Focus Series: Parkinson’s Disease and promising new pre-clinical results from iPS cells Disease Focus Series: a big week of exciting progress on Alzheimer’s Disease Alzheimer’s Disease Disease Focus

Disease Focus Series Read More »

Text mining journal Stem Cells: intriguing comparison to Cell Stem Cell

/ / 1 Comment

I recently did a text mining of all the article titles for Cell Stem Cell for 2012. The results were very insightful (expressed in a beautiful word cloud) for the journal and what are the top areas of focus of authors publishing there. I just did the same analysis for the journal Stem Cells and

Text mining journal Stem Cells: intriguing comparison to Cell Stem Cell Read More »

Text mining Cell Stem Cell: surprising insights into the journal

/ / 1 Comment

Cell Stem Cell was the winner of my 2011 best stem cell journal award (see 2011 awards here, 2012 awards will be announced in early January). As I’ve “complained” in the past, the only thing I wish would be different is they’d publish even more articles per issue or per month! But what exactly does Cell

Text mining Cell Stem Cell: surprising insights into the journal Read More »

Vatican reboots stem cell meeting for 2013, boots ES cell researchers

/ / 6 Comments
Get-out-of-Hell-Free-Card-300x1701

The Vatican is still interested in stem cells and after its own debacle with a stem cell meeting planned for 2012 that turned into a scandal for them. For that original 2012 meeting they had wisely invited a full spectrum of stem cell researchers including those working on embryonic stem cells, to have great discussions.

Vatican reboots stem cell meeting for 2013, boots ES cell researchers Read More »

If Romney wins, look for extremist Witherspoon Council to control his stem cell policy

/ / 1 Comment

The odds of Mitt Romney becoming our next President seem to be increasing. If Romney becomes our next president, what will he do about stem cells? He’ll be an active enemy of embryonic stem cell research. He’ll support the crazy personhood movement. Why do I say that? Earlier this year I had a run in

If Romney wins, look for extremist Witherspoon Council to control his stem cell policy Read More »